NCT00145093View on ClinicalTrials.gov

Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

February 28, 2005

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Baker's yeast (Bio Chromium)

Trial Locations (1)

Unknown

General Practice, Heerde

Sponsors

Collaborators (1)

Pharma Nord
All Listed Sponsors
collaborator

Pharma Nord

INDUSTRY

lead

Medical Research Foundation, The Netherlands

OTHER

NCT00145093 - Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter